Form 4: Protagonist Therapeutics CFO Sells Shares to Cover Tax Obligations

Protagonist Therapeutics' Chief Financial Officer, Asif Ali, sold shares to cover tax obligations related to the settlement of restricted stock units.

Summary

• Asif Ali, the Chief Financial Officer of Protagonist Therapeutics, sold a total of 3,918 shares of common stock on January 16, 2025.
• These sales were executed to cover tax withholding obligations arising from the settlement of restricted stock units.
• The sales were conducted at a price of $0.00, which is likely a placeholder for the actual market price at the time of the transaction.
• Following these transactions, Asif Ali directly owns 62,821 shares of Protagonist Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
• The sale of shares to cover tax obligations is a common occurrence among executives receiving equity compensation.
• The number of shares sold is relatively small compared to the total shares held by the CFO.

Stakeholder Impact

• The sale of shares by the CFO is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Keywords

Protagonist Therapeutics, Asif Ali, stock sale, Form 4, insider trading, tax obligations, restricted stock units, PTGX, CFO